1. Home
  2. KRYS

KRYS

Krystal Biotech Inc.

Logo Krystal Biotech Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-17-2024 10:30am EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Founded: 2015 Country:
United States
United States
Employees: N/A City: PITTSBURGH
Market Cap: 5.0B IPO Year: 2017
Target Price: $165.00 AVG Volume (30 days): 405.3K
Analyst Decision: Strong Buy Number of Analysts: 11
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.39 EPS Growth: N/A
52 Week Low/High: $82.09 - $189.97 Next Earning Date: 05-06-2024
Revenue: $50,699,000 Revenue Growth: N/A
Revenue Growth (this year): 404.19% Revenue Growth (next year): 66.12%

Share on Social Networks: